One Drop
One Drop is a company focused on developing the One Health intradermal continuous glucose monitoring (CGM) device, which integrates AI and micro-needle technology to provide a minimally invasive, pain-free solution for people with type 2 diabetes. The company has discontinued its subscriptions to concentrate on this CGM device, which is currently pending FDA approval.
One Drop Services
One Drop focuses on providing health management technology, with a special emphasis on diabetes care. The company offers the One Drop glucose meter kit, test strips, and lancets through their Amazon Store. They also provide digital health coaching and self-care tracking through the One Drop app, which remains available for free on the Apple App Store and Google Play Store. Previously, One Drop offered subscriptions and chronic condition programs, but these have been discontinued to concentrate on developing their continuous glucose monitor (CGM) technology. Despite the discontinuation, One Drop Premium members retain access to coaching and other features until the end of their billing period.
Products by One Drop
One Drop's product portfolio includes the One Drop glucose meter kit, test strips, and lancets. Their flagship product, the investigational One Health CGM, uses proprietary micro-needle technology combined with AI-enabled precision guidance to deliver minimally invasive, pain-free glucose monitoring tailored for individuals with type 2 diabetes. The device aims to enhance accessibility and affordability. In addition, One Drop offers a free mobile app compatible with Fitbit, Apple Health, Google Fit, and Dexcom, providing users a comprehensive platform to track and manage their health data.
One Drop's Continuous Glucose Monitor (CGM)
The One Health CGM is One Drop's next-generation, AI-enabled continuous glucose monitor. It utilizes micro-needle technology to enable a minimally invasive and pain-free experience. This device is designed for people with type 2 diabetes and aims to provide increased accessibility and affordability. The One Health CGM is currently under investigational status and is awaiting regulatory approval from the U.S. Food and Drug Administration (FDA). The design focuses on cost-effectiveness while integrating advanced AI to improve health outcomes.
One Drop's Clinical Impact
One Drop's technology is supported by over 20 clinical studies showcasing significant impacts on diabetes management. Studies report that One Drop can lower A1C levels by 0.8% to 1.9% within three months, leading to potential cost savings of $1,000 to $2,450 per participant per year. Additional data indicates that One Drop users with type 2 diabetes experienced an A1C reduction of 1.9 percentage points in the same timeframe. Furthermore, One Drop's machine learning models predict glucose levels with 99.5% accuracy at 30 minutes, 98.6% accuracy at one hour, and 91.9% accuracy at four hours.
One Drop in the Health Sector
One Drop operates within the health technology sector, particularly focusing on diabetes management. Their products and services, such as the One Health CGM and the One Drop mobile app, aim to improve health outcomes through innovative technology and AI. The company's emphasis on cost-effective, minimally invasive tools strives to make diabetes care more accessible to the more than 30 million Americans living with type 2 diabetes. By discontinuing subscriptions and chronic condition programs, One Drop is now channeling its efforts towards the development and approval of the One Health CGM to achieve broader market impact.